PIMA512421
CA19-9 Monoclonal Antibody (116-NS-19-9), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA512421-Each-of-1 | In Stock | ₹ 53,988.36 |
PIMA512421 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 53,988.36
GST (18%): ₹ 9,717.905
Total Price: ₹ 63,706.265
Antigen
CA19-9
Classification
Monoclonal
Concentration
Conc. Not Determined
Formulation
tissue culture supernatant with 0.09% sodium azide
Host Species
Mouse
Quantity
500 μL
Primary or Secondary
Primary
Content And Storage
4° C
Form
Liquid
Applications
Immunocytochemistry, Immunohistochemistry (Paraffin)
Clone
116-NS-19-9
Conjugate
Unconjugated
Gene Alias
CA19 9; CA19.9; CA-19.9
Immunogen
Human colon carcinoma cell line SW1116
Regulatory Status
RUO
Target Species
Human
Product Type
Antibody
Isotype
IgG1 κ
Related Products
Description
- MA5-12421 targets CA19-9 in IHC (P) applications and shows reactivity with Human samples
- The MA5-12421 immunogen is human colon carcinoma cell line SW1116
- Mucin glycoprotein is a Sialyl Lewis A structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewis A and/or Lewis B blood group antigens
- In normal tissues, sialyl Lewis A antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands
- Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas
- Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery
- When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings.
Compare Similar Items
Show Difference
Antigen: CA19-9
Classification: Monoclonal
Concentration: Conc. Not Determined
Formulation: tissue culture supernatant with 0.09% sodium azide
Host Species: Mouse
Quantity: 500 μL
Primary or Secondary: Primary
Content And Storage: 4° C
Form: Liquid
Applications: Immunocytochemistry, Immunohistochemistry (Paraffin)
Clone: 116-NS-19-9
Conjugate: Unconjugated
Gene Alias: CA19 9; CA19.9; CA-19.9
Immunogen: Human colon carcinoma cell line SW1116
Regulatory Status: RUO
Target Species: Human
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
CA19-9
Classification:
Monoclonal
Concentration:
Conc. Not Determined
Formulation:
tissue culture supernatant with 0.09% sodium azide
Host Species:
Mouse
Quantity:
500 μL
Primary or Secondary:
Primary
Content And Storage:
4° C
Form:
Liquid
Applications:
Immunocytochemistry, Immunohistochemistry (Paraffin)
Clone:
116-NS-19-9
Conjugate:
Unconjugated
Gene Alias:
CA19 9; CA19.9; CA-19.9
Immunogen:
Human colon carcinoma cell line SW1116
Regulatory Status:
RUO
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Cytokeratin 5/6
Classification: Monoclonal
Concentration: Conc. Not Determined
Formulation: tissue culture supernatant with 0.09% sodium azide
Host Species: Mouse
Quantity: 500 μL
Primary or Secondary: Primary
Content And Storage: 4° C
Form: Liquid
Applications: Immunohistochemistry (Paraffin), Western Blot
Clone: D5/I6 B4
Conjugate: Unconjugated
Gene Alias: 2310016L08Rik; 3300001P10Rik; 58 kDa cytokeratin; 60-kDa keratin; AW146334; CK5; CK-5; CK6A; CK-6A; CK6C; CK-6C; CK6D; CK-6D; CK-6E; cytokeratin 5; cytokeratin 6A; cytokeratin 6C; cytokeratin 6D; cytokeratin-5; Cytokeratin-6A; cytokeratin-6C; Cytokeratin-6D; cytokeratin-6E; DDD; DDD1; EBS2; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; Hom s 5; K5; K6A; K6a keratin; K6C; K6D; kamp-keratin derived antimicrobial peptide; KDAMP; Ker2; keratin 5; keratin 5 (epidermolysis bullosa simplex Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5, type II; keratin 6A; keratin 6A, , type II; keratin 6A, type II; keratin complex 2, basic, gene 5; keratin complex 2, basic, gene 6a; keratin complex 2, basic, gene 6c; keratin complex 2, gene 6a; keratin K6; keratin K6h; keratin, epidermal type II, K6A; keratin, type II cytoskeletal 5; Keratin, type II cytoskeletal 6A; keratin, type II cytoskeletal 6C; keratin-5; keratin-6A; Keratin-6-alpha; keratin-6C; Krt2-5; Krt2-6; Krt2-6a; Krt2-6c; krt5; KRT5A; Krt6; Krt6a; KRT6C; KRT6D; LOC683313; mK6[a]; MK6a; mK6-alpha; PC3; Sak57; similar to keratin complex 2, basic, gene 6a; Tfip8; tuftelin interacting protein 8; type-II keratin Kb12; type-II keratin Kb5; Type-II keratin Kb6
Immunogen: Isolated cytokeratin 5
Regulatory Status: RUO
Target Species: Human, Mouse
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Cytokeratin 5/6
Classification:
Monoclonal
Concentration:
Conc. Not Determined
Formulation:
tissue culture supernatant with 0.09% sodium azide
Host Species:
Mouse
Quantity:
500 μL
Primary or Secondary:
Primary
Content And Storage:
4° C
Form:
Liquid
Applications:
Immunohistochemistry (Paraffin), Western Blot
Clone:
D5/I6 B4
Conjugate:
Unconjugated
Gene Alias:
2310016L08Rik; 3300001P10Rik; 58 kDa cytokeratin; 60-kDa keratin; AW146334; CK5; CK-5; CK6A; CK-6A; CK6C; CK-6C; CK6D; CK-6D; CK-6E; cytokeratin 5; cytokeratin 6A; cytokeratin 6C; cytokeratin 6D; cytokeratin-5; Cytokeratin-6A; cytokeratin-6C; Cytokeratin-6D; cytokeratin-6E; DDD; DDD1; EBS2; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; Hom s 5; K5; K6A; K6a keratin; K6C; K6D; kamp-keratin derived antimicrobial peptide; KDAMP; Ker2; keratin 5; keratin 5 (epidermolysis bullosa simplex Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5, type II; keratin 6A; keratin 6A, , type II; keratin 6A, type II; keratin complex 2, basic, gene 5; keratin complex 2, basic, gene 6a; keratin complex 2, basic, gene 6c; keratin complex 2, gene 6a; keratin K6; keratin K6h; keratin, epidermal type II, K6A; keratin, type II cytoskeletal 5; Keratin, type II cytoskeletal 6A; keratin, type II cytoskeletal 6C; keratin-5; keratin-6A; Keratin-6-alpha; keratin-6C; Krt2-5; Krt2-6; Krt2-6a; Krt2-6c; krt5; KRT5A; Krt6; Krt6a; KRT6C; KRT6D; LOC683313; mK6[a]; MK6a; mK6-alpha; PC3; Sak57; similar to keratin complex 2, basic, gene 6a; Tfip8; tuftelin interacting protein 8; type-II keratin Kb12; type-II keratin Kb5; Type-II keratin Kb6
Immunogen:
Isolated cytokeratin 5
Regulatory Status:
RUO
Target Species:
Human, Mouse
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: EpCAM
Classification: Monoclonal
Concentration: 0.2 mg/mL
Formulation: PBS with 0.05% BSA and 0.05% sodium azide; pH 7.4
Host Species: Mouse
Quantity: 500 μL
Primary or Secondary: Primary
Content And Storage: 4° C
Form: Liquid
Applications: Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Paraffin), Radioimmune Assays (RIA)
Clone: 323/A3
Conjugate: Unconjugated
Gene Alias: adenocarcinoma-associated antigen; CD326; cell surface glycoprotein Trop-1; DIAR5; EGP; EGP-2; EGP314; EGP40; EPCAM; Ep-CAM; EpCAM1; epithelial cell adhesion molecule; Epithelial cell surface antigen; Epithelial glycoprotein; Epithelial glycoprotein 314; ESA; GA733-2; gp40; hEGP314; HNPCC8; human epithelial glycoprotein-2; KS 1/4 antigen; KS1/4; KSA; Ly74; lymphocyte antigen 74; M1S2; M4S1; major gastrointestinal tumor-associated protein GA733-2; mEGP314; membrane component, chromosome 4, surface marker (35kD glycoprotein); MIC18; MK-1; panepithelial glycoprotein 314; protein 289A; Protein D5.7A; Tacsd1; Tacstd1; TROP1; Trop-1 protein; Tumor-associated calcium signal transducer 1
Immunogen: MCF-7 human breast cancer cells
Regulatory Status: RUO
Target Species: Human, Mouse
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
EpCAM
Classification:
Monoclonal
Concentration:
0.2 mg/mL
Formulation:
PBS with 0.05% BSA and 0.05% sodium azide; pH 7.4
Host Species:
Mouse
Quantity:
500 μL
Primary or Secondary:
Primary
Content And Storage:
4° C
Form:
Liquid
Applications:
Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Paraffin), Radioimmune Assays (RIA)
Clone:
323/A3
Conjugate:
Unconjugated
Gene Alias:
adenocarcinoma-associated antigen; CD326; cell surface glycoprotein Trop-1; DIAR5; EGP; EGP-2; EGP314; EGP40; EPCAM; Ep-CAM; EpCAM1; epithelial cell adhesion molecule; Epithelial cell surface antigen; Epithelial glycoprotein; Epithelial glycoprotein 314; ESA; GA733-2; gp40; hEGP314; HNPCC8; human epithelial glycoprotein-2; KS 1/4 antigen; KS1/4; KSA; Ly74; lymphocyte antigen 74; M1S2; M4S1; major gastrointestinal tumor-associated protein GA733-2; mEGP314; membrane component, chromosome 4, surface marker (35kD glycoprotein); MIC18; MK-1; panepithelial glycoprotein 314; protein 289A; Protein D5.7A; Tacsd1; Tacstd1; TROP1; Trop-1 protein; Tumor-associated calcium signal transducer 1
Immunogen:
MCF-7 human breast cancer cells
Regulatory Status:
RUO
Target Species:
Human, Mouse
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: p53
Classification: Monoclonal
Concentration: 0.2 mg/mL
Formulation: PBS with 0.05% BSA and 0.05% sodium azide; pH 7.4
Host Species: Mouse
Quantity: 500 μL
Primary or Secondary: Primary
Content And Storage: 4° C
Form: Liquid
Applications: Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot
Clone: PAb 122
Conjugate: Unconjugated
Gene Alias: Antigen NY-CO-13; bbl; BCC7; bfy; bhy; cellular tumor antigen p53; Cys 51 Stop; EGK_08142; FLJ92943; HGNC11998; I79_002739; LFS1; Li-Fraumeni syndrome; mutant p53; mutant tumor protein 53; OTTMUSP00000006194; p44; p53; p53 cellular tumor antigen; p53 protein; p53 tumor suppressor; p53 tumor suppressor phosphoprotein; phosphoprotein p53; Tp53; tp53.L; transformation related protein 53; transformation-related protein 53; Trp248; Trp53; tumor protein 53; tumor protein p53; tumor protein p53 (Li-Fraumeni syndrome); tumor protein p53 L homeolog; tumor suppressor p53; tumor suppressor p53 phosphoprotein; tumor suppressor protein p53; tumor supressor p53; Tumour Protein p53; XELAEV_180196761mg; Xp53; Xrel3
Immunogen: SV40-transformed mouse B4 cells
Regulatory Status: RUO
Target Species: Hamster, Human, Mouse, Non-human Primate, Rat
Product Type: Antibody
Isotype: IgG2b κ
Antigen:
p53
Classification:
Monoclonal
Concentration:
0.2 mg/mL
Formulation:
PBS with 0.05% BSA and 0.05% sodium azide; pH 7.4
Host Species:
Mouse
Quantity:
500 μL
Primary or Secondary:
Primary
Content And Storage:
4° C
Form:
Liquid
Applications:
Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot
Clone:
PAb 122
Conjugate:
Unconjugated
Gene Alias:
Antigen NY-CO-13; bbl; BCC7; bfy; bhy; cellular tumor antigen p53; Cys 51 Stop; EGK_08142; FLJ92943; HGNC11998; I79_002739; LFS1; Li-Fraumeni syndrome; mutant p53; mutant tumor protein 53; OTTMUSP00000006194; p44; p53; p53 cellular tumor antigen; p53 protein; p53 tumor suppressor; p53 tumor suppressor phosphoprotein; phosphoprotein p53; Tp53; tp53.L; transformation related protein 53; transformation-related protein 53; Trp248; Trp53; tumor protein 53; tumor protein p53; tumor protein p53 (Li-Fraumeni syndrome); tumor protein p53 L homeolog; tumor suppressor p53; tumor suppressor p53 phosphoprotein; tumor suppressor protein p53; tumor supressor p53; Tumour Protein p53; XELAEV_180196761mg; Xp53; Xrel3
Immunogen:
SV40-transformed mouse B4 cells
Regulatory Status:
RUO
Target Species:
Hamster, Human, Mouse, Non-human Primate, Rat
Product Type:
Antibody
Isotype:
IgG2b κ